Cargando…
Preclinical Development of Crocus sativus-Based Botanical Lead IIIM-141 for Alzheimer’s Disease: Chemical Standardization, Efficacy, Formulation Development, Pharmacokinetics, and Safety Pharmacology
[Image: see text] Crocus sativus L. (family: Iridaceae) has been documented in traditional medicine with numerous medicinal properties. Recently, we have shown that C. sativus extract (IIIM-141) displays promising efficacy in a genetic mice (5XFAD) model of Alzheimer’s disease (AD) (ACS Chem. Neuros...
Autores principales: | Bharate, Sonali S., Kumar, Vikas, Singh, Gurdarshan, Singh, Amarinder, Gupta, Mehak, Singh, Deepika, Kumar, Ajay, Vishwakarma, Ram A., Bharate, Sandip B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644748/ https://www.ncbi.nlm.nih.gov/pubmed/31459089 http://dx.doi.org/10.1021/acsomega.8b00841 |
Ejemplares similares
-
Selection of a Water-Soluble Salt Form of a Preclinical
Candidate, IIIM-290: Multiwell-Plate Salt Screening and Characterization
por: Kumar, Vikas, et al.
Publicado: (2018) -
IIIM-941, a Stilbene Derivative Inhibits NLRP3 Inflammasome Activation by Inducing Autophagy
por: Ali, Mehboob, et al.
Publicado: (2021) -
Quantitative Determination and Characterization of
a Kashmir Saffron (Crocus sativus L.)-Based
Botanical Supplement Using Single-Laboratory Validation Study by HPLC-PDA
with LC–MS/MS and HPTLC Investigations
por: Girme, Aboli, et al.
Publicado: (2021) -
Trichoderma lixii (IIIM-B4), an endophyte of Bacopa monnieri L. producing peptaibols
por: Katoch, Meenu, et al.
Publicado: (2019) -
Saffron (Crocus sativus L.): As an Antidepressant
por: Siddiqui, Mohammad J., et al.
Publicado: (2018)